{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:22:11Z","timestamp":1790371331835,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.yebeh.2014.07.018","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T06:32:48Z","timestamp":1408861968000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis"],"prefix":"10.1016","volume":"39","author":[{"given":"Rani A.","family":"Sarkis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8572-3149","authenticated-orcid":false,"given":"Romy","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeina N.","family":"Chemali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.07.018_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"Tuzun","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0404.2012.01691.x","article-title":"The diagnosis and treatment of limbic encephalitis","volume":"126","author":"Asztely","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1590\/S0004-282X2012001000012","article-title":"What should you know about limbic encephalitis?","volume":"70","author":"Machado","year":"2012","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0025","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0030","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0040","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"Hoftberger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","article-title":"Neuronal surface antigen antibodies in limbic encephalitis: clinical\u2013immunologic associations","volume":"71","author":"Graus","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yebeh.2007.03.011","article-title":"Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life","volume":"10","author":"Bien","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0060","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0065","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/WNL.55.12.1823","article-title":"Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy","volume":"55","author":"Bien","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0070","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WNN.0b013e3182248193","article-title":"Spontaneously resolving seronegative autoimmune limbic encephalitis","volume":"24","author":"Najjar","year":"2011","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.2006.100644","article-title":"Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes","volume":"78","author":"Bataller","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0085","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/IJGM.S26523","article-title":"Diagnosing early onset dementia and then what? A frustrating system of aftercare resources","volume":"5","author":"Chemali","year":"2012","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0090","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/gps.1935","article-title":"Do family caregivers perceive more difficulty when they look after patients with early onset dementia compared to those with late onset dementia?","volume":"22","author":"Arai","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0095","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.45.8.1499","article-title":"Complex partial status epilepticus accompanied by serious morbidity and mortality","volume":"45","author":"Krumholz","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11910-011-0209-8","article-title":"Alternative surgical approaches in epilepsy","volume":"11","author":"Gigante","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11910-011-0186-y","article-title":"NMDA receptor antibody encephalitis","volume":"11","author":"Irani","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0110","first-page":"366","article-title":"Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis","volume":"18","author":"Rosenfeld","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2014.07.018_bb0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505014002716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:55:43Z","timestamp":1538286943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505014002716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":24,"alternative-id":["S1525505014002716"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.07.018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}